中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2015年
6期
1142-1144
,共3页
朱磊%朱俊岭%钮明杨%胡丹%祁伯祥
硃磊%硃俊嶺%鈕明楊%鬍丹%祁伯祥
주뢰%주준령%뉴명양%호단%기백상
熊去氧胆酸%婴儿肝炎综合征%细胞因子
熊去氧膽痠%嬰兒肝炎綜閤徵%細胞因子
웅거양담산%영인간염종합정%세포인자
KEY WORDS] Ursodeoxycholic acid%Infantile hepatitis syndrome%Cytokines
目的:观察熊去氧胆酸治疗婴儿肝炎综合征的临床疗效,并初步探讨其药理机制。方法:选择76例婴儿肝炎综合征患儿为研究对象,根据治疗方法不同分为常规治疗组及熊去氧胆酸治疗组,另选择同期门诊体检健康儿童20名作为对照组。常规治疗组给予抗病毒、护肝等治疗,熊去氧胆酸治疗组在常规治疗组基础上加用熊去氧胆酸(10 mg? kg-1? d-1),疗程为2~3周。治疗2周后,比较常规治疗组和熊去氧胆酸治疗组治疗前后血清总胆红素(TBIL)、直接胆红素(DBIL)、谷丙转氨酶(ALT)、谷氨酰转肽酶(GGT)、总胆汁酸(TBA)和TNF-α、IL-6的变化情况。结果:(1)婴儿肝炎综合征患儿血清TNF-α和IL-6均明显高于对照组(P<0.01)。(2)常规治疗组患儿治疗后血清TBIL、DBIL、ALT、GGT、TBA及TNF-α和IL-6均较治疗前下降,差异有统计学意义( P<0.01)。(3)熊去氧胆酸治疗组患儿治疗后血清TBIL、DBIL、ALT、GGT、TBA及TNF-α和IL-6均较常规治疗组显著降低,差异有统计学意义(P<0.01)。结论:在常规治疗基础上加用熊去氧胆酸能更有效减轻婴儿肝炎综合征患儿全身炎症反应,减轻肝脏损伤。
目的:觀察熊去氧膽痠治療嬰兒肝炎綜閤徵的臨床療效,併初步探討其藥理機製。方法:選擇76例嬰兒肝炎綜閤徵患兒為研究對象,根據治療方法不同分為常規治療組及熊去氧膽痠治療組,另選擇同期門診體檢健康兒童20名作為對照組。常規治療組給予抗病毒、護肝等治療,熊去氧膽痠治療組在常規治療組基礎上加用熊去氧膽痠(10 mg? kg-1? d-1),療程為2~3週。治療2週後,比較常規治療組和熊去氧膽痠治療組治療前後血清總膽紅素(TBIL)、直接膽紅素(DBIL)、穀丙轉氨酶(ALT)、穀氨酰轉肽酶(GGT)、總膽汁痠(TBA)和TNF-α、IL-6的變化情況。結果:(1)嬰兒肝炎綜閤徵患兒血清TNF-α和IL-6均明顯高于對照組(P<0.01)。(2)常規治療組患兒治療後血清TBIL、DBIL、ALT、GGT、TBA及TNF-α和IL-6均較治療前下降,差異有統計學意義( P<0.01)。(3)熊去氧膽痠治療組患兒治療後血清TBIL、DBIL、ALT、GGT、TBA及TNF-α和IL-6均較常規治療組顯著降低,差異有統計學意義(P<0.01)。結論:在常規治療基礎上加用熊去氧膽痠能更有效減輕嬰兒肝炎綜閤徵患兒全身炎癥反應,減輕肝髒損傷。
목적:관찰웅거양담산치료영인간염종합정적림상료효,병초보탐토기약리궤제。방법:선택76례영인간염종합정환인위연구대상,근거치료방법불동분위상규치료조급웅거양담산치료조,령선택동기문진체검건강인동20명작위대조조。상규치료조급여항병독、호간등치료,웅거양담산치료조재상규치료조기출상가용웅거양담산(10 mg? kg-1? d-1),료정위2~3주。치료2주후,비교상규치료조화웅거양담산치료조치료전후혈청총담홍소(TBIL)、직접담홍소(DBIL)、곡병전안매(ALT)、곡안선전태매(GGT)、총담즙산(TBA)화TNF-α、IL-6적변화정황。결과:(1)영인간염종합정환인혈청TNF-α화IL-6균명현고우대조조(P<0.01)。(2)상규치료조환인치료후혈청TBIL、DBIL、ALT、GGT、TBA급TNF-α화IL-6균교치료전하강,차이유통계학의의( P<0.01)。(3)웅거양담산치료조환인치료후혈청TBIL、DBIL、ALT、GGT、TBA급TNF-α화IL-6균교상규치료조현저강저,차이유통계학의의(P<0.01)。결론:재상규치료기출상가용웅거양담산능경유효감경영인간염종합정환인전신염증반응,감경간장손상。
[ ABSTRACT] AIM:To observe the effect of ursodeoxycholic acid ( UDCA) on the treatment of infantile hepatitis syndrome ( HIS) and to investigate its mechanism.METHODS:The children with infantile hepatitis syndrome were divid-ed into conventional treatment group and the UDCA treatment group.Twenty healthy children were selected as normal con-trol.The children in conventional therapy group were given antiviral and hepatoprotective treatments.The children in UD-CA treatment group were given ursodeoxycholic acid (10 mg? kg-1? d-1 ) in addition to the conventional treatment group for 2 to 3 weeks.The levels of total bilirubin (TBIL), direct bilirubin (DBIL), alanine aminotransferase (ALT), glu-tamyltransferase ( GGT) , total bile acids ( TBA) and TNF-α, IL-6 were detected before admission and 2 weeks later.RE-SULTS:The levels of TNF-αand IL-6 were significantly higher in the children with IHS than those in the normal control (P<0.01).The levels of TBIL, DBIL, ALT, GGT, TBA, TNF-αand IL-6 in conventional treatment group were reduced after therapy (P<0.01).All the above index in UDCA treatment group were decreased compared with conventional treat-ment group (P<0.01).CONCLUSION:On the basis of conventional therapy, ursodeoxycholic acid effectively alleviates the systemic inflammatory response in the children with IHS, reduces the liver damages.